Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up

被引:26
作者
Zeng, Jing [1 ]
Sun, Chao [1 ]
Sun, Wan Lu [1 ]
Chen, Guang Yu [1 ]
Pan, Qin [1 ]
Yan, Shi Yan [1 ]
Xu, Zheng Jie [1 ]
Chen, Yuan Wen [1 ]
Fan, Jian Gao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Gastroenterol,Ctr Fatty Liver, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
chronic kidney disease; controlled attenuation parameter; estimated glomerular filtration rate; fatty liver index; non-alcoholic fatty liver disease; NONALCOHOLIC FATTY LIVER; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; MORTALITY; TRANSPLANTATION; STEATOHEPATITIS; PREVALENCE; FIBROSIS; IMPACT; INDEX;
D O I
10.1111/1751-2980.12465
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: To explore the association between chronic kidney disease (CKD), graded by the estimated glomerular filtration rate (eGFR), and nonalcoholic fatty liver disease (NAFLD) using controlled attenuation parameter (CAP) and fatty liver index (FLI) values in Chinese adults undergoing routine health examinations. METHODS: A total of 731 adult participants without diabetes mellitus or significant alcohol consumption who underwent routine health examinations were included. Their eGFR, CAP, FLI and abdominal ultrasonography results were assessed. RESULTS: The prevalence of ultrasound-diagnosed NAFLD and CKD (eGFR <60 mL/min per 1.73 m(2)) was 36.1% and 6.6%, respectively. CKD was more common in NAFLD patients than in those without (10.6% vs 4.3%, P < 0.001). The CAP and FLI values were significantly higher in the NAFLD group than in those without, but the change in the eGFR was negligible between the two groups. eGFR was negatively correlated with CAP (r = -0.189, P = 0.003) and FLI values (r = -0.130, P = 0.045). Moreover, eGFR was significantly lower in participants with CAP > 292 dBm or FLI = 60 than in those with CAP < 238 dBm or FLI < 30, respectively (both P < 0.05). The CAP value (odds ratio [OR] 1.099, 95% confidence interval [CI] 1.091-1.108, P = 0.021) was an independent risk factor for CKD. CONCLUSIONS: A diagnosis of hepatic steatosis is related to an increased risk of CKD among nonalcoholic and non-diabetic Chinese adults regardless of whether the diagnosis was acquired via ultrasound, CAP or FLI. Increased hepatic lipid content may contribute to CKD development.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 29 条
[1]   Impact of treating the metabolic syndrome on chronic kidney disease [J].
Agrawal, Varun ;
Shah, Aashish ;
Rice, Casey ;
Franklin, Barry A. ;
McCullough, Peter A. .
NATURE REVIEWS NEPHROLOGY, 2009, 5 (09) :520-528
[2]   Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate [J].
Allen, Alina M. ;
Kim, W. Ray ;
Therneau, Terry M. ;
Larson, Joseph J. ;
Heimbach, Julie K. ;
Rule, Andrew D. .
JOURNAL OF HEPATOLOGY, 2014, 61 (02) :286-292
[3]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[4]   Epidemiology of alcoholic and nonalcoholic fatty liver disease in China [J].
Fan, Jian-Gao .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 :11-17
[5]   Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study [J].
Ferraro, Pietro Manuel ;
Lupo, Antonio ;
Yabarek, Tewoldemedhn ;
Graziani, Maria Stella ;
Bonfante, Luciana ;
Abaterusso, Cataldo ;
Gambaro, Giovanni .
METABOLIC SYNDROME AND RELATED DISORDERS, 2011, 9 (05) :381-388
[6]   Renal Function in Patients Undergoing Transplantation for Nonalcoholic Steatohepatitis Cirrhosis: Time to Reconsider Immunosuppression Regimens? [J].
Houlihan, Diarmaid D. ;
Armstrong, Matthew J. ;
Davidov, Yana ;
Hodson, James ;
Nightingale, Peter ;
Rowe, Ian A. ;
Paris, Sue ;
Gunson, Bridget K. ;
Bramhall, Simon B. ;
Mutimer, David J. ;
Neuberger, James M. ;
Newsome, Philip N. .
LIVER TRANSPLANTATION, 2011, 17 (11) :1292-1298
[7]   Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes [J].
Hwang, S. T. ;
Cho, Y. K. ;
Yun, J. W. ;
Park, J. H. ;
Kim, H. J. ;
Park, D. I. ;
Sohn, C. I. ;
Jeon, W. K. ;
Kim, B. I. ;
Rhee, E. J. ;
Oh, K. W. ;
Lee, W. Y. ;
Jin, W. .
INTERNAL MEDICINE JOURNAL, 2010, 40 (06) :437-442
[8]   Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals [J].
Johns, Barry R. ;
Pao, Alan C. ;
Kim, Sun H. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) :1410-1415
[9]   Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States [J].
Kim, Donghee ;
Kim, W. Ray ;
Kim, Hwa Jung ;
Therneau, Terry M. .
HEPATOLOGY, 2013, 57 (04) :1357-1365
[10]   The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report [J].
Levey, Andrew S. ;
de Jong, Paul E. ;
Coresh, Josef ;
El Nahas, Meguid ;
Astor, Brad C. ;
Matsushita, Kunihiro ;
Gansevoort, Ron T. ;
Kasiske, Bertram L. ;
Eckardt, Kai-Uwe .
KIDNEY INTERNATIONAL, 2011, 80 (01) :17-28